A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

John S. Lambert, Michael C. Keefer, Mark J. Mulligan, David H. Schwartz, Jiri Mestecky, Kent J. Weinhold, Carol Smith, Ray Hsieh, Zina Moldoveanu, Patricia Fast,

Vaccine · 2001 · 50 citations · 29 references

Concepts

References

29